Safety and Pharmacodynamic Study of ABT-436 in Major Depressive Disorder
NCT01380704
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
51
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
ABT-436
DRUG:
Matching Placebo
Sponsor
AbbVie